» Articles » PMID: 32311089

Atopic Dermatitis in the Elderly Caucasian Population: Diagnostic Clinical Criteria and Review of the Literature

Overview
Journal Int J Dermatol
Specialty Dermatology
Date 2020 Apr 21
PMID 32311089
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atopic dermatitis (AD) is a chronic relapsing eczematous dermatitis typically affecting young patients in a percentage from 15 to 20%; although it typically affects young people and adults, recent papers highlighted the emerging of the disease in the elderly population.

Methods: The aim of the study was to identify the clinical criteria and allergic sensitization that may be able to support physicians and dermatologists in making a correct diagnosis of AD in the elderly. The second aim of this study was to investigate the incidence, the main features, the gender prevalence, the immunological profile, and comorbidities characterizing patients older than 65 years affected by AD.

Results: Based on clinical and serological patterns, different phenotypes of AD were identified: generalized AD (55%) characterized by eczematous lesions involving typical areas of the body or prurigo nodularis-like AD; chronic eczematous hand dermatitis (23%); face and neck involvement (9%); and nummular eczema (13%). Skin prick tests revealed a positivity for aeroallergens in 49.6% of patients, most of them being polysensitized (55%). Additionally, food skin prick tests were positive in 25% of patients. Most of the patients reported comorbidities, particularly IgE-mediated diseases, such as seasonal rhino-conjunctivitis, asthma, and chronic obstructive pulmonary disease. Gastrointestinal symptoms such as meteorism, dyspepsia, cramps/abdominal pain, and diarrhea/constipation, were observed in 35% of patients consequent to food allergy.

Conclusion: In our study, we suggest clinical and serological criteria that may be able to guide in the diagnosis of AD in Caucasian elderly, and to design an appropriate treatment according to the current standard protocol.

Citing Articles

Dupilumab as Therapeutic Option in Polysensitized Atopic Dermatitis Patients Suffering from Food Allergy.

Sernicola A, Amore E, Rizzuto G, Rallo A, Greco M, Battilotti C Nutrients. 2024; 16(16).

PMID: 39203933 PMC: 11356865. DOI: 10.3390/nu16162797.


Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.

Guglielmo A, Deotto M, Naldi L, Stinco G, Pileri A, Piraccini B Dermatol Reports. 2024; 16(2):9839.

PMID: 38957642 PMC: 11216152. DOI: 10.4081/dr.2023.9839.


Association Between Atopic Dermatitis and Aging: Clinical Observations and Underlying Mechanisms.

Chen P, Shen M, Cai S, Tang Z J Inflamm Res. 2024; 17:3433-3448.

PMID: 38828054 PMC: 11144009. DOI: 10.2147/JIR.S467099.


Evaluation of severe adverse cutaneous drug reactions in patients admitted to tertiary care center: A cross-sectional study.

Moshayedi M, Asilian A, Mokhtari F Health Sci Rep. 2024; 7(3):e1969.

PMID: 38486684 PMC: 10937814. DOI: 10.1002/hsr2.1969.


Current and Emerging Therapies for Atopic Dermatitis in the Elderly.

Teng Y, Zhong H, Yang X, Tao X, Fan Y Clin Interv Aging. 2023; 18:1641-1652.

PMID: 37810952 PMC: 10558003. DOI: 10.2147/CIA.S426044.